本页面由Tiger Trade Technology Pte. Ltd.提供服务

Regulus Therapeutics Inc

8.16
0.0000
成交量:- -
成交额:7,591.12万
市值:5.65亿
市盈率:-11.28
高:8.16
开:8.16
低:8.16
收:8.16
52周最高:8.35
52周最低:0.8301
股本:6,923.41万
流通股本:5,293.84万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.7233
每股收益(LYR):-0.8227
净资产收益率:-53.82%
总资产收益率:-34.23%
市净率:8.18
市盈率(LYR):-9.92

数据加载中...

2024/05/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/17

SEC问询函

Form CORRESP - Correspondence
2024/03/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/06

SEC问询函

Form CORRESP - Correspondence
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report